Jaya Goswami
Overview
Explore the profile of Jaya Goswami including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
296
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Goswami J, Cardona J, Hsu D, Simorellis A, Wilson L, Dhar R, et al.
Lancet Infect Dis
. 2024 Nov;
PMID: 39608389
Background: Coadministration of a respiratory syncytial virus (RSV) vaccine with seasonal influenza or SARS-CoV-2 vaccines could reduce health-care visits and increase vaccination uptake in older adults who are at high...
2.
Panozzo C, Walsh E, Yang Z, Wilson E, Goswami J, Stoszek S, et al.
Infect Dis Ther
. 2024 Nov;
14(1):275-281.
PMID: 39549152
Introduction: As no standard case definitions for respiratory syncytial virus-associated lower respiratory tract disease (RSV-LRTD) in adults are available, this study analyzed definitions for severe RSV-LRTD from previously published data...
3.
Fitz-Patrick D, Mihara H, Mills A, Mithani R, Kapoor A, Dhar R, et al.
Respir Investig
. 2024 Sep;
62(6):1037-1043.
PMID: 39255587
Background: Respiratory syncytial virus (RSV) represents a global health concern, including in older adults. This study assessed the safety and immunogenicity of mRNA-1345, an investigational mRNA RSV vaccine, in adults...
4.
Goswami J, Baqui A, Doreski P, Marc G, Jimenez G, Ahmed S, et al.
J Infect Dis
. 2024 Jun;
230(5):e996-e1006.
PMID: 38889247
Background: The mRNA-1345 vaccine demonstrated efficacy against respiratory syncytial virus (RSV) disease with acceptable safety in adults aged ≥60 years in the ConquerRSV trial. Here, humoral immunogenicity results from the...
5.
Shaw C, Essink B, Harper C, Mithani R, Kapoor A, Dhar R, et al.
J Infect Dis
. 2024 Feb;
230(3):e647-e656.
PMID: 38385566
Background: An mRNA-based respiratory syncytial virus (RSV) vaccine, mRNA-1345, is under clinical investigation to address RSV disease burden in older adults. Methods: Based on a randomized, observer-blind, placebo-controlled design, this...
6.
Wilson E, Goswami J, Baqui A, Doreski P, Perez-Marc G, Zaman K, et al.
N Engl J Med
. 2023 Dec;
389(24):2233-2244.
PMID: 38091530
Background: Respiratory syncytial virus (RSV) can cause substantial morbidity and mortality among older adults. An mRNA-based RSV vaccine, mRNA-1345, encoding the stabilized RSV prefusion F glycoprotein, is under clinical investigation....
7.
Chebrolu P, Laux T, Chowdhury S, Seth B, Ranade P, Goswami J, et al.
Indian J Tuberc
. 2020 Jun;
67(2):152-158.
PMID: 32553304
Background: A secondary care hospital in rural India serving a highly tuberculosis (TB) and malnutrition endemic region. Objective: In this study conducted on patients with chronic protein energy malnutrition (PEM)...
8.
Divala T, Mungwira R, Mawindo P, Nyirenda O, Kanjala M, Ndaferankhande M, et al.
Lancet Infect Dis
. 2018 Sep;
18(10):1097-1107.
PMID: 30195996
Background: Sulfadoxine-pyrimethamine resistance threatens efficacy of intermittent preventive treatment of malaria during pregnancy, and alternative regimens need to be identified. With the return of chloroquine efficacy in southern Africa, we...
9.
Travassos M, Beyene B, Adam Z, Campbell J, Mulholland N, Diarra S, et al.
PLoS One
. 2016 Mar;
11(3):e0149970.
PMID: 26934372
Objective: Demographic and health surveys, immunization coverage surveys and administrative data often divergently estimate vaccination coverage, which hinders pinpointing districts where immunization services require strengthening. We assayed vaccination coverage in...
10.
Goswami J, Hernandez-Santos N, Zuniga L, Gaffen S
Eur J Immunol
. 2009 Sep;
39(10):2831-9.
PMID: 19731364
Post-menopausal osteoporosis is considered to be an inflammatory process, in which numerous pro-inflammatory and T-cell-derived cytokines play a bone-destructive role. IL-17A is the signature cytokine of the pro-inflammatory Th17 population...